...
首页> 外文期刊>Photodiagnosis and Photodynamic Therapy >Synthesis of calcium phosphate nanostructures by combustion in solution as a potential encapsulant system of drugs with photodynamic properties for the treatment of cutaneous leishmaniasis
【24h】

Synthesis of calcium phosphate nanostructures by combustion in solution as a potential encapsulant system of drugs with photodynamic properties for the treatment of cutaneous leishmaniasis

机译:通过溶液燃烧合成磷酸钙纳米结构,作为具有光动力学性质的潜在封装药物系统,用于治疗皮肤利什曼病

获取原文
获取原文并翻译 | 示例
           

摘要

The traditional drugs used in the treatment of cutaneous leishmanisis (CL) have multiple disadvantages, such as high toxicity, high costs, and more recently the appearance of parasites resistant to those drugs. For this reason, some research has focused on the development of new drugs or treatment therapies. Photodynamic therapy (PDT) that involves the use of a photosensitive or photosensitizing compound capable of producing reactive oxygen species to which Leishmania parasites are sensitive, has emerged as an alternative for the treatment of CL. However, some of these sensitizing compounds exhibit some toxicity (cytotoxicity, allergic reaction, etc), low selectivity, and some of them are insoluble in aqueous media limiting their use. Therefore, the PDT can be improved using encapsulation systems which protect drugs, prevent their degradation, help them overcome physical barriers and increase their selectivity. In this study, we propose the use of calcium phosphate as a potential encapsulant or photodynamic support for photoactive drugs, using hypericin (HY) as a photosensitizer agent. The self -combustion route was used to synthesize the CP nanostructures. The structure and morphology of CP nanoparticles were evaluated via X-ray diffraction (XRD), Raman and field -emission scanning electron microscopy (FE-SEM). Phases rich in hydroxyapatite and CP beta phase, with granular morphology and an average grain size of 42.9 nm were obtained. The encapsulation uptake and the interactions between HY and the encapsulated system were evaluated by fluorescence spectroscopy and Fourier -transform infrared spectroscopy (FTIR), respectively. Approximately 13% of HY was enapsulated per 1 pg of nanoparticles of calcium phosphate. Composites were submitted to in vitro assays of cytotoxicity and anti-leishmanial activity. The CP nanoparticles did not affect the photodynamic activity of HY. On the contrary they showed antileishmanial response.
机译:用于治疗皮肤利什曼原虫(CL)的传统药物具有多个缺点,例如高毒性,高成本以及最近出现了对那些药物具有抗性的寄生虫。因此,一些研究集中在新药或治疗疗法的开发上。已经出现了涉及使用光敏或光敏化合物的光动力疗法(PDT),该光敏或光敏化合物能够产生对利什曼原虫寄生虫敏感的活性氧,作为治疗CL的替代方法。然而,这些敏化化合物中的一些表现出一定的毒性(细胞毒性,过敏反应等),选择性低,并且它们中的一些不溶于水介质,从而限制了它们的使用。因此,可以使用保护药物,防止其降解,帮助其克服物理障碍并提高其选择性的封装系统来改善PDT。在这项研究中,我们建议使用金丝桃素(HY)作为光敏剂,将磷酸钙用作光敏药物的潜在封装剂或光动力支持物。自燃路线用于合成CP纳米结构。通过X射线衍射(XRD),拉曼光谱和场发射扫描电子显微镜(FE-SEM)评估了CP纳米颗粒的结构和形态。获得了富含羟基磷灰石和CPβ相的相,具有颗粒形态和平均晶粒尺寸为42.9 nm。分别通过荧光光谱和傅里叶变换红外光谱(FTIR)评估了HY和封装系统之间的封装吸收和相互作用。每1 pg磷酸钙纳米颗粒中约含13%的HY。将复合材料进行细胞毒性和抗利什曼活性的体外测定。 CP纳米粒子不影响HY的光动力活性。相反,他们表现出反种族主义的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号